tirzepatide and appendicitis glp 1 appendicitis What are the considerations for using tirzepatide (a dual GIP (glucose-dependent insulinotropic polypeptide) GLP-1 (glucagon-like peptide-1) receptor agonist) in patients with pre-existing Zepbound Side Effects & Safety:

The choice between these medications depends on a variety of factors, including health history, goals, response to treatment, and provider recommendations

Patients who use it to support structured protocols consistently outperform those relying on dietary restriction alone

Due to risks for decreased bioavailability of birth control pills, the manufacturer of Mounjaro (tirzepatide) recommends that patients either use barrier contraception for four weeks after initiation or dosage increase or switch to a non-oral contraceptive

[3] In this group of women, oocyte fertilization, embryo quality, and pregnancy rates were lower, while their early miscarriage rate was higher